The Combined Effect of Endurance Training and Atorvastatin on Serum Interleukin-10 Levels Following Experimental Myocardial Infarction in Rats
DOI:
https://doi.org/10.22100/jkh.v11i4.1532Keywords:
Endurance exercise training, Atorvastatin, Interleukin-10, Myocardial infarction, RatAbstract
Introduction: Atorvastatin and endurance training (ET) may have synergic positive effects on inflammation process, following myocardial infarction (MI). Therefore, the present study aimed to investigate the combined effect of endurance training and three doses of atorvastatin on serum interleukin-10 (IL-10) levels following experimental myocardial infarction in rats.
Methods: 75 rats (age 8-10 weeks and 230±10 g body weight) were randomly divided to 9 groups. Sham, control, endurance training, atorvastatin (5, 10 and 15 mg/kg), and exercise plus atorvastatin (5, 10 and 15 mg/kg). MI was induced by subcutaneous injection of isoprenaline (150 mg/kg) in two consecutive days. Drug and training intervention was initiated 2 days after MI and continued for 4 weeks. Data were analyzed by using one-way analyses of variance (ANOVA) at P<0.05 level.
Results: Combined ET with taking 10 mg/kg atorvastatin significantly increased serum levels of IL-10 (P=0.001), but the combined effect of ET and atorvastatin (5 and 15 mg/kg), ET alone and three doses of atorvastatin alone (5, 10 and 15 mg/kg) was not significant.
Conclusion: It seems that combined endurance training with taking 10 mg/kg atorvastatin is the best combination that can improve the inflammatory condition after MI.
References
World Health Organization. The top ten causes of death. Fact sheet number 310. May 2011:2.
Salehi L, Haidari F. Efficacy of PRECEDE model in promoting nutritional behaviors in a rural society. Iran J Epidemiol 2011;6:21-7.
Elmadbouh I, Mansour M, Nabeh M, Faried W, Abdelsabour A, Omar A. Atorvastatin improves cardiac function and remodeling in chronic non-ischemic heart failure: A clinical and pre-clinical study. The Egyptian Heart Journal 2015;67:289-98. doi: 10.1016/j.ehj.2014.11.003
Liu J, Wang H, Li J. Inflammation and Inflammatory cells in myocardial infarction and reperfusion injury: a double-edged Sword. Clin Med Insights Cardiol 2016;10:79-84. doi: 10.4137/CMC.S33164
Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 2014;11:255-65. doi: 10.1038/nrcardio.2014.28
de Haan JJ, Smeets MB, Pasterkamp G, Arslan F. Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediators Inflamm 2013;2013:206039. doi: 10.1155/2013/206039
Zhang DF, Song XT, Chen YD, Yuan F, Xu F, Zhang M, et al. Prognostic performance of interleukin-10 in patients with chest pain and mild to moderate coronary artery lesions-an 8-year follow-up study. J Geriatr Cardiol 2016;13:244-51. doi: 10.11909/j.issn.1671-5411.2016.03.012
Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 2009;104:e9-18. doi: 10.1161/CIRCRESAHA.108.188243
Joshi NV, Toor I, Shah AS, Carruthers K, Vesey AT, Alam SR, et al. Systemic atherosclerotic inflammation following acute myocardial infarction: myocardial infarction begets myocardial infarction. J Am Heart Assoc 2015;4:e001956. doi: 10.1161/JAHA.115.001956
Ozguler IM, Burma O, Uysal A, Akbulut H. Rosuvastatin lowers systemic inflammatory response in coronary artery bypass graft accompanied by cardiopulmonary bypass surgery: a randomized controlled study. Clin invest med 2015;38:E154-63.
Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765. doi: 10.1146/annurev.immunol.19.1.683
Waehre T, Halvorsen B, Damas JK, Yndestad A, Brosstad F, Gullestad L, et al. Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10. Eur J Clin Invest 2002;32:803-10.
Kesherwani V, Chavali V, Hackfort BT, Tyagi SC, Mishra PK. Exercise ameliorates high fat diet induced cardiac dysfunction by increasing interleukin 10. Front Physiol 2015;6:124. doi: 10.3389/fphys.2015.00124
Kaur K, Sharma AK, Singal PK. Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 2006;291:H106-13. doi: 10.1152/ajpheart.01327.2005
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78. doi: 10.1016/S0140-6736(05)67394-1
Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al. Atorvastatin for acute coronary syndromes. Jama 2001;286:533-5.
Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504. doi: 10.1056/NEJMoa040583
Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 2006;47:332-7. doi: 10.1016/j.jacc.2005.06.088
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207. doi: 10.1056/NEJMoa0807646
Forsberg PO, Li X, Sundquist K. Neighborhood socioeconomic characteristics and statin medication in patients with myocardial infarction: a Swedish nationwide follow-up study. BMC Cardiovasc Disord 2016;16:146. doi: 10.1186/s12872-016-0319-y
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med 1996;335:1001-9. doi: 10.1056/NEJM199610033351401
Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs 2008;8:373-418. doi: 10.2165/0129784-200808060-00004
Doustar Y, Mohajeri D. The anti-apoptotic effects of atorvastatin in isoproterenol induced experimental heart failure. Zahedan Journal of Research in Medical Sciences 2011;13:13-9.
Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American heart association exercise, cardiac rehabilitation, and prevention committee, the council on clinical cardiology; the councils on cardiovascular nursing, epidemiology and prevention, and nutrition, physical activity, and metabolism; and the american association of cardiovascular and pulmonary rehabilitation. Circulation 2007;115:2675-82. doi: 10.1161/circulationaha.106.180945
Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011;11:607-15. doi: 10.1038/nri3041
Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 2006;42:105-17. doi: 10.1042/bse0420105
Rodrigues B, Lira FS, Consolim-Colombo FM, Rocha JA, Caperuto EC, De Angelis K, et al. Role of exercise training on autonomic changes and inflammatory profile induced by myocardial infarction. Mediators Inflamm 2014;2014:702473. doi: 10.1155/2014/702473
Jain M, Liao R, Ngoy S, Whittaker P, Apstein CS, Eberli FR. Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats. Cardiovasc Res 2000;46:66-72.
Benatti FB, Pedersen BK. Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation. Nat Rev Rheumatol 2015;11:86-97. doi: 10.1038/nrrheum.2014.193
Viana JL, Kosmadakis GC, Watson EL, Bevington A, Feehally J, Bishop NC, et al. Evidence for anti-inflammatory effects of exercise in CKD. J Am Soc Nephrol 2014;25:2121-30. doi: 10.1681/ASN.2013070702
Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J Appl Physiol 2007;103:1093-8. doi: 10.1152/japplphysiol.00080.2007
Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 2003;285:E433-7. doi: 10.1152/ajpendo.00074.2003
Ribeiro F, Alves AJ, Teixeira M, Miranda F, Azevedo C, Duarte JA, et al. Exercise training increases interleukin-10 after an acute myocardial infarction: a randomised clinical trial. Int J Sports Med 2012;33:192-8. doi: 10.1055/s-0031-1297959
Galvão TF, Matos KC, Brum PC, Negrão CE, Luz PLd, Chagas ACP. Cardioprotection conferred by exercise training is blunted by blockade of the opioid system. Clinics 2011;66:151-7. doi:10.1590/S1807-59322011000100026
Zaafan MA, Zaki HF, El-Brairy AI, Kenawy SA. Protective effects of atorvastatin and quercetin on isoprenaline-induced myocardial infarction in rats. Bulletin of Faculty of Pharmacy, Cairo University 2013;51:35-41. doi: 10.1016/j.bfopcu.2013.03.001
Shukla SK, Sharma SB, Singh UR. β-Adrenoreceptor agonist isoproterenol alters oxidative status, inflammatory signaling, injury markers and apoptotic cell death in myocardium of rats. Indian J Clin Biochem 2014;30:27-34. doi: 10.1007/s12291-013-0401-5
Wu G, Rana JS, Wykrzykowska J, Du Z, Ke Q, Kang P, et al. Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarction. Am J Physiol Heart Circ Physiol 2009;296:H389-95. doi: 10.1152/ajpheart.01393.2007
de Waard MC, van der Velden J, Bito V, Ozdemir S, Biesmans L, Boontje NM, et al. Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction. Circulation Research 2007;100:1079-88. doi: 10.1161/01.RES.0000262655.16373.37
Xu X, Zhao W, Lao S, Wilson BS, Erikson JM, Zhang JQ. Effects of exercise and L-arginine on ventricular remodeling and oxidative stress. Med Sci Sports Exerc 2010;42:346-54.
Xu X, Wan W, Ji L, Lao S, Powers AS, Zhao W, et al. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats. Cardiovasc Res 2008;78:523-32. doi: 10.1093/cvr/cvn028
Stumpf C, Petzi S, Seybold K, Wasmeier G, Arnold M, Raaz D, et al. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction. Clin Sci 2009;116:45-52. doi: 10.1042/CS20080042
Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M, et al. Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 2011;2:e244. doi: 10.1038/cddis.2011.130
Walter DH, Dimmeler S, Zeiher AM. Effects of statins on endothelium and endothelial progenitor cell recruitment. Semin Vasc Med 2004;4:385-93. doi: 10.1055/s-2004-869595
Bogdanis GC, Nevill ME, Boobis LH, Lakomy HK. Contribution of phosphocreatine and aerobic metabolism to energy supply during repeated sprint exercise. J Appl Physiol 1996;80:876-84.
Hejazi M, Nezamdoost Z, Saghebjoo M. Effect of twelve weeks of aerobic training on serum levels of leptin, vaspin and some indicators of oxidative stress in obese middle-aged women. Iranian Journal of Endocrinology and Metabolism 2014;16:111-8.
Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer 2013;12: 86. doi: 10.1186/1476-4598-12-86
Spangenburg EE, Brown DA, Johnson MS, Moore RL. Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. J Physiol 2006;572:839-48. doi: 10.1113/jphysiol.2005.104315
Dominguez Rodriguez A, Abreu Gonzalez P, Garcia Gonzalez MJ, Ferrer Hita J. Association between serum interleukin 10 level and development of heart failure in acute myocardial infarction patients treated by primary angioplasty. Rev Esp Cardiol 2005;58:626-30.
Moustardas P, Kadoglou NP, Katsimpoulas M, Kapelouzou A, Kostomitsopoulos N, Karayannacos PE, et al. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice. PloS One 2014;9:e108240. doi: 10.1371/journal.pone.0108240
Guazzi M, Tumminello G, Reina G, Vicenzi M, Guazzi MD. Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients. Eur J Clin Invest 2007;37:454-62. doi: 10.1111/j.1365-2362.2007.01805.x
Stumpf C, Petzi S, Seybold K, Wasmeier G, Arnold M, Raaz D, et al. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction. Clin Sci 2009;116:45-52. doi: 10.1042/CS20080042
Batista ML Jr, Lopes RD, Seelaender MC, Lopes AC. Anti-inflammatory effect of physical training in heart failure: role of TNF-alpha and IL-10. Arq Bras Cardiol 2009;93:643-51,92-700.
Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005;98:1154-62. doi: 10.1152/japplphysiol.00164.2004
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
